Teva Branded Pharmaceutical Products R&D, Inc.
teva.comTotal trials
208
Active
0
Phase 3
92
Total enrollment
65,970
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Asthma42
- Parkinson's Disease12
- Relapsing Remitting Multiple Sclerosis9
- Migraine8
- Multiple Sclerosis7
- Pharmacokinetics5
- Eosinophilic Asthma5
- Solid Tumors4
Frequently asked questions about Teva Branded Pharmaceutical Products R&D, Inc.
- How many clinical trials does Teva Branded Pharmaceutical Products R&D, Inc. have on ClinicalTrials.gov?
- Teva Branded Pharmaceutical Products R&D, Inc. is listed as the lead sponsor on 208 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Teva Branded Pharmaceutical Products R&D, Inc.'s trials are in Phase 3?
- 92 of Teva Branded Pharmaceutical Products R&D, Inc.'s trials are in Phase 3.
- What therapeutic areas does Teva Branded Pharmaceutical Products R&D, Inc. focus on?
- Teva Branded Pharmaceutical Products R&D, Inc.'s most-studied conditions on ClinicalTrials.gov are Asthma, Parkinson's Disease, Relapsing Remitting Multiple Sclerosis, Migraine, Multiple Sclerosis.